Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -18.63% is 96% above its 3-year average of -479.67%, near the high end of its 3-year range (-855.45%–-18.63%).
As of the fiscal period ended Thursday, March 31, 2022. 96.61% above its 12-month average of -550.13%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
-18.63%
EBITDA MARGIN AVG TTM
-550.13%
EBITDA MARGIN AVG 3Y
-479.67%
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+96.61%
CURRENT VS 3Y AVG
+96.12%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Scholar Rock Holding Corporation
Market Cap
$6.81B
EBITDA Margin
-18.63%
TTM Avg
-550.13%
3Y Avg
-479.67%
5Y Avg
N/A
Market Cap
$6.78B
EBITDA Margin
15.93%
TTM Avg
16.80%
3Y Avg
17.55%
5Y Avg
18.41%
Market Cap
$6.60B
EBITDA Margin
6.82%
TTM Avg
6.08%
3Y Avg
-0.44%
5Y Avg
-8.67%
Market Cap
$7.77B
EBITDA Margin
-3.14%
TTM Avg
-1.08%
3Y Avg
-5.02%
5Y Avg
-19.32%
Market Cap
$5.41B
EBITDA Margin
21.06%
TTM Avg
20.50%
3Y Avg
18.63%
5Y Avg
16.67%
Market Cap
$10.04B
EBITDA Margin
10.47%
TTM Avg
10.43%
3Y Avg
10.38%
5Y Avg
10.85%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scholar Rock Holding Corporation (SRRK) | $6.81B | -18.63% | -550.13% | -479.67% | N/A |
| Chemed Corporation (CHE)vs › | $6.78B | 15.93% | 16.80% | 17.55% | 18.41% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.60B | 6.82% | 6.08% | -0.44% | -8.67% |
| Oscar Health, Inc. (OSCR)vs › | $7.77B | -3.14% | -1.08% | -5.02% | -19.32% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.41B | 21.06% | 20.50% | 18.63% | 16.67% |
| Doximity, Inc. (DOCS)vs › | $5.00B | 35.56% | 38.69% | 36.58% | 34.55% |
| The Ensign Group, Inc. (ENSG)vs › | $10.04B | 10.47% | 10.43% | 10.38% | 10.85% |
| Henry Schein, Inc. (HSIC)vs › | $10.23B | 8.11% | 8.11% | 8.28% | 8.19% |
| Insulet Corp. (PODD)vs › | $10.30B | 21.67% | 20.24% | 16.36% | 15.66% |
| Universal Health Services, Inc. (UHS)vs › | $10.31B | 15.05% | 14.69% | 13.35% | 14.10% |
Gross Margin
0.0%
EBITDA Margin
-18.6%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2022-03-31 | -18.63% |
| 2021-12-31 | -855.45% |
| 2021-09-30 | -666.25% |
| 2021-06-30 | -644.96% |
| 2021-03-31 | -565.36% |
| 2020-12-31 | -750.44% |
| 2020-09-30 | -764.90% |
| 2020-06-30 | -488.95% |
| 2020-03-31 | -344.00% |
| 2019-12-31 | -157.94% |
| 2019-09-30 | -351.38% |
| 2019-06-30 | -259.40% |
| 2019-03-31 | -368.06% |
